Zentalis Pharmaceuticals (ZNTL)
(Delayed Data from NSDQ)
$3.31 USD
+0.03 (0.91%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $3.30 -0.01 (-0.30%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.83 | 0.00% |
Earnings Summary
For their last quarter, Zentalis Pharmaceuticals (ZNTL) reported earnings of $0.14 per share, beating the Zacks Consensus Estimate of $-0.85 per share. This reflects a positive earnings surprise of 116.47%. Look out for ZNTL's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year increase of 55.14%.
Earnings History
Price & Consensus
Zacks News for ZNTL
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
ZNTL: What are Zacks experts saying now?
Zacks Private Portfolio Services